Decisions of Cramo Plc's Annual General Meeting of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
46
Decisions of Cramo Plc's Annual General Meeting of Shareholders

Vantaa, Finland, 2017-03-30 13:00 CEST (GLOBE NEWSWIRE) -- Cramo Plc    Stock Exchange Release 30 March 2017, at 2.00 pm Finnish time (EET)

Decisions of Cramo Plc's Annual General Meeting of Shareholders The Annual General Meeting of Shareholders of Cramo Plc was held in Helsinki on Thursday, 30 March 2017.

1 Matters pertaining to the Annual General Meeting

The Annual General Meeting adopted the consolidated financial statements and the parent company's financial statements for the financial year 2016 and discharged the members of the Board of Directors and the CEO from liability. The Annual General Meeting of Shareholders decided that, as proposed by the Board of Directors, a dividend of EUR 0.75 per share will be paid for the financial year 1 January – 31 December 2016. The dividend will be paid to shareholders registered in the shareholders’ register of the Company held by Euroclear Finland Ltd on the record date of the dividend payment 3 April 2017. The dividend will be paid on 10 April 2017. The number of the members of the Board of Directors was confirmed as seven (7) ordinary members. Mr Perttu Louhiluoto, Mr Peter Nilsson, Mr Joakim Rubin, Mr Raimo Seppänen, Mr Erkki Stenberg and Ms Caroline Sundewall were re-elected as Board members and Mr Veli-Matti Reinikkala as new Board member, all for a term of office ending at the end of the Annual General Meeting 2018. The Annual General Meeting resolved that the Chairman of the Board of Directors shall be paid EUR 70,000 per year, the Deputy Chairman of the Board of Directors EUR 40,000 per year, and the other members of the Board of Directors EUR 35,000 per year. It was further resolved that 50 per cent of the annual remuneration will be paid in Cramo shares purchased on the market on behalf of the Board members. The remuneration may also be paid by transferring the Company’s own shares based on the authorisation given to the Board of Directors by the General Meeting of Shareholders. In case such purchase of shares is not carried out due to reasons related to either the Company or a Board member, the annual remuneration shall be paid entirely in cash. In addition, it was decided that all Board members are entitled to a compensation of EUR 1,000 per attended Board committee meeting and that the member of the Board elected in the position of Chairman of the Audit Committee would receive an additional compensation of EUR 5,000 per year. Reasonable travel expenses will be refunded in accordance with an invoice. The Annual General Meeting decided that the Auditors will be paid reasonable remuneration in accordance with the invoice approved by the Company.   The audit firm KPMG Oy Ab was appointed as Cramo Plc's Auditor for the term ending at the end of the next Annual General Meeting, with APA Mr Toni Aaltonen as the responsible auditor.

2 Authorisation to decide on the acquisition of Company’s own shares and/or on the acceptance as pledge of the Company’s own shares

The Annual General Meeting authorised the Board of Directors to decide on the acquisition of the Company's own shares and/or on the acceptance as pledge of the Company's own shares as follows:

The amount of own shares to be acquired and/or accepted as pledge shall not exceed 4,400,000 shares in total, which corresponds to approximately 10 per cent of all of the shares in the Company. However, the Company together with its subsidiaries cannot at any moment own and/or hold as pledge more than 10 per cent of all the shares in the Company. Only the unrestricted equity of the Company can be used to acquire own shares on the basis of the authorisation.

Own shares can be acquired at a price formed in public trading on Nasdaq Helsinki on the date of the acquisition or otherwise at a price formed on the market.

The Board of Directors decides how own shares will be acquired and/or accepted as pledge. Own shares can be acquired using, inter alia, derivatives. Own shares can be acquired otherwise than in proportion to the shareholdings of the shareholders (directed acquisition).

Own shares can be acquired and/or accepted as pledge to, among other things, limit the dilutive effects of share issues carried out in connection with possible acquisitions, to develop the Company's capital structure, to be transferred in connection with possible acquisitions, to be used in incentive arrangements or to be cancelled, provided that the acquisition is in the interest of the Company and its shareholders. However, not more than 400,000 shares acquired under this authorisation may be used for the incentive arrangements of the Company.

The authorisation is effective until the end of the next Annual General Meeting of Shareholders, however no longer than until 30 September 2018.

3 Authorisation of the Board of Directors to decide on share issue, as well as option rights and other special rights entitling to shares

The Annual General Meeting authorised the Board of Directors to decide on share issue as well as issue of option rights and other special rights entitling to shares, pursuant to Chapter 10 of the Companies Act as follows:

The shares issued under the authorisation are new or those in the Company's possession. Under the authorisation, a maximum of 4,400,000 shares, which corresponds to approximately 10 per cent of all of the shares in the Company, can be issued. The shares or other special rights entitling to shares can be issued in one or more tranches.

Under the authorisation, the Board of Directors may resolve upon issuing new shares to the Company itself. However, the Company, together with its subsidiaries, cannot at any time own more than 10 per cent of all its registered shares.

The Board of Directors is authorised to resolve on all terms for the share issue and granting of the special rights entitling to shares. The Board of Directors is authorised to resolve on a directed share issue and issue of the special rights entitling to shares in deviation from the shareholders’ pre-emptive right, provided that there is a weighty financial reason for the Company to do so. Except for issuing of option rights for incentive arrangements, the authorisation can also be used for incentive arrangements, however, not more than 400,000 shares in total.

The proposed authorisation invalidates prior resolved and registered authorisations made at the General Meeting of Shareholders regarding share issue, issuing of option rights and other special rights entitling to shares as well as transfer of the Company's own shares.

The authorisation is valid until the end of the next Annual General Meeting of Shareholders, however no longer than until 30 September 2018.

4 Adoption of the charter of the Shareholders' Nomination Committee

The Annual General Meeting decided that the charter of the Nomination Committee shall be revised.

According to the adopted charter the charter shall be adopted in the Annual General Meeting only if the Nomination Committee proposes changes to the charter. In addition, minor technical changes were adopted.

CRAMO PLC

Leif Gustafsson President and CEO

Further information:

Mr Leif Gustafsson, President and CEO, tel: +358 10 661 10 Mr Mattias Rådström, SVP, Communication, Marketing and Investor Relations, tel: +46 70 868 7045

Distribution:

Nasdaq Helsinki Ltd. Principal media www.cramogroup.com

Cramo is Europe’s second largest rental services company specialising in construction machinery and equipment rental and rental-related services as well as the rental of modular space. Cramo operates in fifteen countries and in about 320 depots. With a group staff around 2,600, Cramo's consolidated sales in 2016 was EUR 712 million. Cramo shares are listed on Nasdaq Helsinki Ltd.

Read more: www.cramogroup.com , www.twitter.com/cramogroup

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 2

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

BrightNight Enhances Strategy with Yanara Spin-Off for Growth

Updated Category News Views 250

BrightNight Unveils New Structure for Enhanced Focus BrightNight has made a significant change in its operational framework by spinning off its Asia Pacific (APAC) business, creating two independent entities. This strategic move allows BrightNight to solely concentrate on the burgeoning US market while Yanara will handle the APAC region. By establishing Yanara as a...

Continue Reading
FICO's New Algorithm Revolutionizes Optimization Challenges

Updated Category News Views 193

FICO Introduces Groundbreaking Algorithm for Optimization Solutions FICO (NYSE: FICO), a prominent name in global analytics software, has recently celebrated an impressive achievement in the field of mathematical optimization. The company's innovative researchers developed a remarkably efficient algorithm designed to tackle challenging optimization problems that may...

Continue Reading
Celebrating 20 Years of Profit Launch Workshops for Contractors

Updated Category News Views 143

BDR's Legacy in Training and Coaching Business Development Resources (BDR) has carved out a significant niche over the last twenty years as a key player in training and coaching within the home services sector. These guys aren’t just tossing around fluff; they're all about rolling up sleeves and diving into the gritty details that matter most to contractors—think...

Continue Reading
Exploring the Growing Demand for Laser Hair Removal Services

Updated Category News Views 175

The Surge in Laser Hair Removal Demand As grooming practices evolve, the demand for effective hair removal solutions has steadily increased. Recent research indicates that the laser hair removal market, currently valued at $1 billion, is projected to soar to $7.7 billion by the year 2035. This remarkable growth translates to a compound annual growth rate (CAGR) of 18.3%...

Continue Reading
Row Zero Secures $10 Million in Funding for Enhanced Spreadsheet

Updated Category News Views 306

Row Zero Secures New Funding to Innovate in Big Data Analytics Row Zero, known as The Enterprise Spreadsheet, has successfully raised $10 million in seed funding. This significant capital infusion will help the company accelerate its development efforts and deliver innovative solutions tailored for handling big data securely and effectively. Details About the Funding This...

Continue Reading